New renderings have been revealed for the four-structure life-sciences infill at 120 East Grand Avenue in South San Francisco, San Mateo County. The project is set for review by the city’s Planning Commission this Thursday, during which the commission is expected to vote on the environmental review findings. Trammell Crow Company is the developer.
CA Ventures has withdrawn plans for their 14-story life sciences building at 5850 Shellmound Way in Emeryville, Alameda County. The move comes as the life science market has been slowing down across the Bay Area, and many new projects are coming online in the coming years.
Plans are moving through the city for the life sciences proposal at 200 Kansas Street in San Francisco. The application was approved for a streamlined environmental review process by the planning department in November of last year, and the filing has been under review ever since. The project is a joint venture with Kinship Capital and Presidio Bay Ventures.
Renderings and details have been released for 1125 O’Brien Drive in Menlo Park, San Mateo County. The five-story development is the third new R&D office space proposed by the same developer for an industrial neighborhood across from Facebook’s proposed mixed-use Willow Village. Tarlton Properties is the project sponsor and building owner.
The City of San Carlos has approved plans for a three-story R&D building at 888 Bransten Road in San Carlos, San Mateo County. The decision comes after the Environmental Impact Report concluded that construction would not have a significant effect on the environment. The property was sold in late 2021 from Black Mountain Properties to Alexandria Real Estate Properties.
